Qi Liu, PhD, of the U.S. Food and Drug Administration, discusses the findings from our collaborative research

Qi Liu, PhD, of the U.S. Food and Drug Administration, discusses data that suggest that patients with advanced non–small cell lung cancer who had a past medical history of pneumonitis were more likely to experience treatment-associated pneumonitis in response to immune checkpoint inhibitors or chemotherapy.

See the video here.